Sommaire

• • ·Cancer clusters: how can we improve understanding?

    Page :1129

     
• • ·Nobel prizes in physiology or medicine: more in cancer?

    Page :1130-1131

    Joe Simone

     
• • ·Adjuvant chemotherapy: how much is enough?

    Page :1132-1133

    Ruth M O’Regan

     
• • ·New insights into the role of HIV infection on cancer risk

    Page :1133-1134

    Michael J Silverberg, Chun Chao, Donald I Abrams

     
• • ·Curing Hodgkin’s lymphoma: quantity and quality

    Page :1134-1135

    Andrew M Evens, Lynne I Wagner

     
• • ·Reducing costs of colon polyp management

    Page :1135-1136

    Douglas K Rex

     
• • ·Retrospective subset analyses in early breast cancer revisited

    Page :1136-1137

    Miguel Martin, Parham Khosravi

     
• • ·Circulating tumour cells as more than prognostic markers

    Page :1138-1139

    Justin Stebbing, Long R Jiao

      
• • ·Cetuximab and panitumumab: are they interchangeable?

    Page :1140-1141

    Richard Kim

     
• • ·Brachytherapy for medically inoperable lung cancer

    Page :1141-1142

    Daya Nand Sharma, Goura Kishor Rath

    
• • ·Screening newborns for TP53

    Page :1142

    Joel Zlotogora

    
• • ·Errata

    Page :1142

    
• • ·Errata

    Page :1142

    
• • ·A review of human carcinogens—Part F: Chemical agents and related occupations

    Page :1143-1144

    Robert Baan, Yann Grosse, Kurt Straif, Béatrice Secretan, Fatiha El Ghissassi, Véronique Bouvard, Lamia Benbrahim-Tallaa, Neela Guha, Crystal Freeman, Laurent Galichet, Vincent Cogliano, on behalf of the WHO International Agency for Research on Cancer Monograph Working Group

     
• • ·Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial

    Page :1145-1151

    Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, Riikka Huovinen, Arja Jukkola-Vuorinen, Minna Tanner, Raija Asola, Riitta Kokko, Johan Ahlgren, Päivi Auvinen, Akseli Hemminki, Outi Paija, Leena Helle, Lauri Nuortio, Kenneth Villman, Greger Nilsson, Sirpa-Liisa Lahtela, Kaisa Lehtiö, Marjo Pajunen, Paula Poikonen, Paul Nyandoto, Vesa Kataja, Petri Bono, Mika Leinonen, Henrik Lindman, on behalf of the FinXX Study Investigators

    Résumé Résumé Plan Plan  
• • ·Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study

    Page :1152-1159

    Marguerite Guiguet, François Boué, Jacques Cadranel, Jean-Marie Lang, Eric Rosenthal, Dominique Costagliola, on behalf of the Clinical Epidemiology Group of the FHDH-ANRS CO4 cohort ‡

    Résumé Résumé Plan Plan   
• • ·Quality of life after successful treatment of early-stage Hodgkin’s lymphoma: 10-year follow-up of the EORTC–GELA H8 randomised controlled trial

    Page :1160-1170

    Natacha Heutte, Henning H Flechtner, Nicolas Mounier, Wilhelmina AM Mellink, Jacobus H Meerwaldt, Houchingue Eghbali, Mars B van’t Veer, Evert M Noordijk, Johanna C Kluin-Nelemans, Elzbieta Lampka, José Thomas, Pieternella J Lugtenburg, Luisa Viterbo, Patrice Carde, Anton Hagenbeek, Richard WM van der Maazen, Wilma GJM Smit, Pauline Brice, Marinus van Marwijk Kooy, Johanna W Baars, Philip Poortmans, Umberto Tirelli, Onno C Leeksma, Radka Tomšič, Pierre Feugier, Gilles Salles, Jean Gabarre, Marie José Kersten, Eric Van Den Neste, Geert-Jan M Creemers, Isabelle Gaillard, Paul Meijnders, Gérard Tertian, Oumédaly Reman, Hein P Muller, Jacques Troncy, Michel Blanc, Wilfried Schroyens, Paul J Voogt, Pierre Wijermans, Chantal Rieux, Christophe Fermé, Michel Henry-Amar, for the EORTC-GELA H8 Trial Group ‡

    Résumé Résumé Plan Plan   
• • ·Optical diagnosis of small colorectal polyps at routine colonoscopy (Detect InSpect ChAracterise Resect and Discard; DISCARD trial): a prospective cohort study

    Page :1171-1178

    Ana Ignjatovic, James E East, Noriko Suzuki, Margaret Vance, Thomas Guenther, Brian P Saunders

    Résumé Résumé Plan Plan  
• • ·Evolving novel anti-HER2 strategies

    Page :1179-1187

    Kellie L Jones, Aman U Buzdar

    Résumé Résumé Plan Plan  
• • ·Clinical management of uterine sarcomas

    Page :1188-1198

    Frédéric Amant, An Coosemans, Maria Debiec-Rychter, Dirk Timmerman, Ignace Vergote

    Résumé Résumé Plan Plan   
• • ·Birt-Hogg-Dubé syndrome: diagnosis and management

    Page :1199-1206

    Fred H Menko, Maurice AM van Steensel, Sophie Giraud, Lennart Friis-Hansen, Stéphane Richard, Silvana Ungari, Magnus Nordenskjöld, Thomas vO Hansen, John Solly, Eamonn R Maher, on behalf of the European BHD Consortium

    Résumé Résumé Plan Plan  
• • ·Defining the surgical planes on MRI improves surgery for cancer of the low rectum

    Page :1207-1211

    Oliver C Shihab, Richard J Heald, Eric Rullier, Gina Brown, Torbjorn Holm, Philip Quirke, Brendan J Moran

    Résumé Résumé Plan Plan  
• • ·Familial breast cancer: the first linkage

    Page :1212

    Alan Ashworth